omega-n-methylarginine has been researched along with EHS Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flitney, FW; Hirst, DG; Kennovin, GD | 1 |
| Chung, HT; Jun, CD; Kim, HM; Yoon, HJ | 1 |
| Gonzales, S; Hibbs, JB; Kwon, OD; McGregor, JR; Samlowski, WE; Yim, CY | 1 |
3 other study(ies) available for omega-n-methylarginine and EHS Tumor
| Article | Year |
|---|---|
"Upstream" modification of vasoconstrictor responses in rat epigastric artery supplying an implanted tumour.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Arteries; In Vitro Techniques; Neoplasm Transplantation; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylephrine; Rats; Rats, Inbred Strains; Sarcoma, Experimental; Vasoconstriction | 1994 |
Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
Topics: Animals; Arginine; Cytotoxicity, Immunologic; Fibronectins; Interferon-gamma; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Nitric Oxide; omega-N-Methylarginine; Recombinant Proteins; Sarcoma, Experimental; Tumor Necrosis Factor-alpha | 1995 |
Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice.
Topics: Animals; Capillary Permeability; Enzyme Inhibitors; Female; Immunotherapy; In Vitro Techniques; Infusion Pumps; Interleukin-2; Killer Cells, Lymphokine-Activated; Male; Mice; Mice, Inbred C3H; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Recombinant Proteins; Sarcoma, Experimental | 1995 |